By Sharecast
Date: Wednesday 31 Dec 2025
31 December 2025
Electric Guitar PLC
("Electric Guitar" or the "Company")
Half year Report
Electric Guitar plc (AIM:ELEG), announces its unaudited interim results for the six months ended 30 September 2025.
Highlights
· £1.4m liabilities derecognised following the Company Voluntary Arrangement ('CVA') becoming unconditional
· £0.9m net profit for the period as a result of the derecognition of the CVA liabilities
· Trading in the Company's shares restored on 2 April 2025 following initial £0.3m recapitalisation
· £0.8m further equity placing on 18 June 2025
· Trading in the Company's shares suspended again from 25 June 2025 pending new reverse takeover ('RTO')
· Agreement in principle announced on 18 July 2025 to acquire Dunbar Energy Inc. ('Dunbar')
· £0.5m cash at bank at 30 September 2025 to cover further anticipated RTO costs and overheads
Post balance sheet events
· CVA completed on 8 October 2025, with 'debt for equity' shares issued on 13 October 2025 in exchange for the £1.4m of liabilities and the remaining £45k of convertible loans
· Proposed Dunbar RTO discussions continue with a view to completion in Q1 2026
Contacts:
Electric Guitar PLC Richard Horwood
| info@electricguitarplc.com |
Allenby Capital (Nominated Adviser and Joint Broker) Jeremy Porter / Piers Shimwell (Corporate Finance) Amrit Nahal / Kelly Gardiner (Equity Sales & Corporate Broking)
| 020 3328 5656
|
AlbR Capital (Joint Broker) Jon Belliss / Colin Rowbury | 020 3026 0320 |
CHAIR'S STATEMENT
For the six months ended 30 September 2025
I present the Company's unaudited interim results for the six months ended 30 September 2025.
Achievements during the six months ended 30 September 2025
Following approval of the Company's CVA at the end of March and the Company's initial recapitalisation and restoration to trading of its shares in April, I'm pleased to report a much more stable and positive picture compared to the prior half year.
Led during the period by Richard Horwood, who had already capably steered the Company through approval of its CVA and the initial £0.3m recapitalisation process, and with the Board strengthened at the start of April by the appointment of experienced investment manager, Sarfraz Munshi, we have been able to embark confidently on the next stage of the Company's journey.
In June we raised a further £0.8m in equity to cover the anticipated costs of our next proposed acquisition as well as our regular working capital needs, before trading in our shares was automatically again suspended under AIM rules for having spent 6 months as a cash shell.
This additional investment led in July to our being able to announce an agreement in principle to acquire US energy and digital infrastructure company, Dunbar, in an all-share transaction. Dunbar's business is focused on the provision of so-called 'behind the meter' on-site electricity generation, and the deployment of modular compute facilities, to provide a diverse range of energy and infrastructure solutions for the high-performance computing industry. Modular compute facilities are data centres built from pre-engineered, factory-made components that can be quickly deployed, scaled and relocated, offering greater agility, cost-efficiency and adaptability for modern IT needs like AI.
Although demand for datacentres and compute sites continues to grow rapidly, not least due to the rapid development of AI, it is hampered by the greatly increased demand for the large amounts of electricity they consume. Dunbar addresses this by establishing its sites close to gas wells it will control that are able to produce gas that is typically too remote from the main gas pipeline networks to be cost-effectively monetised.
Such gas can be efficiently converted into electricity on-site, reducing the need for the compute facilities to have to draw power from an increasingly overstretched electricity supply grid - hence the expression 'behind-the-meter'.
Post balance sheet events
After our CVA Supervisor settled claims from preferential creditors such as HMRC, the CVA was finally completed on 8 October 2025, with 'debt for equity' shares issued in exchange for the £1.4m liabilities and the remaining £45k of convertible loans, leaving the Company debt free.
Detailed discussions have continued since reaching the agreement in principle to acquire Dunbar, reflecting on-going developments in Dunbar's business opportunities and asset acquisitions.
Finalising these discussions has delayed the due diligence process and therefore the signing of definitive legal agreements. However, we expect the proposed RTO to be put to shareholders for approval in the first quarter of 2026.
We look forward to updating shareholders in due course.
Grahame Cook
Chair
31 December 2025
The results for the period are set out on page 10. For the six months ended 30 September 2025, the Company reports a net profit of £900k (2024: net loss of £4,268k) for the Company and its subsidiaries ('Group').
During the six months ended 30 September 2025, the Company incurred one-off expenses in respect of the proposal to acquire US energy company Dunbar Energy Inc. in an all-share RTO, subject (inter alia) to due diligence and approval by the Company's shareholders.
Current liabilities of £1.4m included in the Company's and Consolidated Statement of Financial Position at 31 March 2025 were derecognised in April 2025 following proposals for the Company's CVA becoming unconditional. These liabilities therefore no longer existed after April 2025 and the derecognition of these has been credited to the Income Statement.
During the period, the Group incurred a net cash inflow of £297k (2024: outflow of £30k). At 30 September 2025, the Company held cash at bank of £537k.
No dividends were paid. The directors do not recommend payment of an interim dividend.
The financial statements have been prepared on a going concern basis. See note 2.3 for key matters assessed by the Directors in determining that the half-year financial statements should be prepared on a going concern basis.
Richard Horwood
Director
|
Note | Six months ended 30/9/25 |
| Six months ended 30/9/24 |
|
| £'000 |
| £'000 |
Continuing operations | ||||
Other income: | ||||
- Derecognition of liabilities | 4 | 1,351 | - | |
Administration expenses: - Acquisition costs - Other costs |
6
|
(259) (193) |
(585) - | |
Operating profit / (loss) |
| 899 |
| (585) |
|
|
|
| |
Finance costs | (1) | (5) | ||
Finance income- interest received | 2 | 3 | ||
Profit / (loss) before income tax | 900 |
| (587) | |
Income tax | - | - | ||
Profit / (loss) for the period from continuing operations |
| 900 |
| (587) |
Loss from discontinued operations | 7 | - | (3,681) | ||||||||||||
Profit / (loss) for the period Other comprehensive income: | 900 | (4,268) | |||||||||||||
Items that may be reclassified to profit or loss | |||||||||||||||
Gains on translation of foreign operations | - | 28 |
| ||||||||||||
|
| ||||||||||||||
Profit / (loss) and other comprehensive income for the period |
| 900 |
| (4,240) |
| ||||||||||
Earnings (loss) per share: |
| ||||||||||||||
Basic (pence) - continuing operations | 8 | 0.05 | - |
| |||||||||||
Basic (pence) - discontinued operations | - | (2.13) |
| ||||||||||||
Diluted (pence) | 0.04 | (2.13) |
| ||||||||||||
|
| At 30 Sept 2025 |
| At 31 March 2025 |
Note | £'000 |
| £'000 | |
| (unaudited) | (audited) | ||
NON-CURRENT ASSETS |
|
|
| |
Property, plant and equipment | 2 |
| 3 | |
|
|
|
| |
CURRENT ASSETS |
|
|
| |
Receivables and prepayments | 130 | 9 | ||
Assets classified as held for sale | 12 | 32 | 32 | |
Cash and cash equivalents |
| 537 | 240 | |
|
| 699 |
| 281 |
| ||||
TOTAL ASSETS |
| 701 | 284 | |
| ||||
SHAREHOLDERS' EQUITY |
| |||
Share capital | 9 | 1,481 | 1,286 | |
Share premium Foreign currency translation reserve | 9 | 4,585 (56) | 3,704 (56) | |
Share-based payment reserve | 9 | 84 | 64 | |
Accumulated losses | (6,128) | (7,028) | ||
TOTAL EQUITY- (deficiency) | (34) | (2,030) | ||
CURRENT LIABILITIES |
|
|
|
|
Borrowings | 10 | 45 |
| 55 |
Trade and other payables | 11 | 85 | 1,404 | |
Liabilities classified as held for sale | 12 | 570 | 570 | |
Shares to be issued |
| 35 | 285 | |
TOTAL LIABILITIES | 735 | 2,314 | ||
|
|
| ||
TOTAL EQUITY AND LIABILITIES | 701 | 284 | ||
|
|
|
|
These financial statements were approved by the Board of Directors and authorised for issue on 31 December 2025 and were signed on its behalf by:
Richard Horwood, Director
Company number 13288812
Share capital | Share premium | Retained losses | Share-based payment reserve | Foreign currency trans-lation reserve | Totals | |
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 |
| ||||||
At 1 April 2025 | 1,286 | 3,704 | (7,028) | 64 | (56) | (2,030) |
| ||||||
Changes in equity |
| |||||
New shares issued during the period | 195 | 920 | - | - | - | 1,115 |
Costs of share issues | - | (39) | - | - | - | (39) |
Share based payments | - | - | - | 20 | - | 20 |
Profit for the period | - | - | 900 | - | - | 900 |
At 30 September 2025 (unaudited) | 1,481 | 4,585 | (6,128) | 84 | (56) | (34) |
| ||||||
At 1 April 2024 (audited) | 289 | 949 | (2,146) | - | - | (908) |
Change in equity |
| |||||
New shares issued during the period | 927 | 2,700 | - | - | - | 3,627 |
Share based payments | - | - | - | 49 | - | 49 |
Foreign exchange translation gains | - | - | - | - | 28 | 28 |
Loss for the period | - | - | (4,268) | - | - | (4,268) |
At 30 September 2024 (unaudited) | 1,216 | 3,649 | (6,414) | 49 | 28 | (1,472) |
6 months ended 30 Sept 2025 |
| 6 months ended 30 Sept 2024 |
| ||
£'000 |
| £'000 |
| ||
Cash flow from operating activities | (unaudited) | (unaudited) |
| ||
Profit / (loss) for the period | 900 | (4,268) |
| ||
|
| ||||
Adjustments for: |
|
| |||
Derecognition of CVA liabilities | (1,351) | - |
| ||
Finance costs | - | 5 |
| ||
Finance income | (2) | (3) |
| ||
Share-based payment charges | 20 | 49 |
| ||
Depreciation charges | - | 1 |
| ||
Impairment of goodwill | - | 2,269 |
| ||
Foreign currency differences | - | (28) |
| ||
(Increase) / decrease in other receivables | (117) | 74 |
| ||
Increase in trade and other payables | 94 | 535 |
| ||
Net cash used in operating activities |
| (456) |
| (1,366) |
|
| |||||
Cash flow from investing activities |
| ||||
Finance income | 2 | 3 |
| ||
Net cash from investing activities |
| 2 |
| 3 |
|
| |||||
Cash flow from financing activities |
| ||||
Proceeds from issue of shares | 751 | 1,323 |
| ||
Net proceeds from borrowings | - | 10 |
| ||
Net cash from financing activities |
| 751 |
| 1,333 |
|
|
|
|
|
|
|
Net increase / (decrease) in cash and cash equivalents |
| 297 |
| (30) |
|
|
|
|
|
|
|
Cash and cash equivalents at the beginning of the period |
|
240 |
|
- |
|
Cash acquired on acquisition of subsidiaries |
| - |
| 53 |
|
|
|
|
|
| |
Cash and cash equivalents at the end of the period |
| 537 |
| 23 |
|
|
|
|
|
| |
Electric Guitar Plc is a public limited company, registered in England and Wales. The Company's registered office is One Bartholomew Close, London, EC1A 7BL.
In May 2024, the Company cancelled the listing of its Ordinary shares on the Standard Segment of the Official List and its Ordinary shares were admitted to trading on AIM, a market operated by the London Stock Exchange. Further to the Company's announcement of 24 December 2024 regarding the liquidation of 3radical, the Company's operating subsidiary, the Company was reclassified as a cash shell pursuant to Rule 15 of the AIM Rules. Restoration of trading in its Ordinary shares on AIM took place on 2 April 2025, and was suspended again on 25 June 2025 as it had not acquired a new trading company within 6 months of its becoming a cash shell.
Following approval of the Company's CVA on 27 March 2025 and the Company's main subsidiary 3radical being put into liquidation, the principal activity of the Company during the period to 30 September 2025 was that of identifying potential companies, businesses, or assets for acquisition. The 3radical liquidation is currently in progress with the value of asset realisations to be confirmed on completion, which the directors are advised is expected in the first half of 2026.
The functional and presentational currency is Great British Pounds Sterling ('£') and the financial statements have been rounded to nearest thousands of pounds (£'000).
The following significant accounting policies have been applied:
These half-year financial statements for the Company and its subsidiaries ('the Group') have been prepared under the historical cost convention and in accordance with the recognition and measurement requirements of UK adopted International Financial Reporting Standards (UK adopted IFRS).
In December 2024, 3radical, the Company's main subsidiary was put into liquidation. The directors also restructured the operations and debt of the Company through a CVA in March 2025 which was formally completed in October 2025. Assets are held at their net realisable value. Liabilities are stated at their expected settlement amount.
NOTES TO THE INTERIM FINANCIAL STATEMENTS
As 3radical has been placed into administration and a creditors' voluntary liquidation ('CVL'), the financial position and results relating to this company and its subsidiary entities at 30 September 2025 have been accounted for on a basis other than going concern in the condensed consolidated financial statements for the period ended 30 September 2025. Accordingly, all assets and liabilities relating to these companies have been classified as current, and assets have been written down to their estimated realisable value at 30 September 2025.
The financial statements have been prepared on a going concern basis. The Board has assessed the Company's financial position as at 30 September 2025 and the factors which may impact the Company's ability to continue as a going concern for a period of at least 12 months from the date of approval of these financial statements.
As at 30 September 2025, the Group had a deficiency in total equity of £34,000. Excluding other income from the derecognition of liabilities arising from the CVA, the Group generated a loss for the period ended 30 September 2025 of £451,000 and a net cash outflow from operating activities of £456,000. The deficiency in equity of £34,000 at 30 September 2025 was after current liabilities of £1.4 million were derecognised in April 2025 following proposals for the Company's CVA becoming unconditional. These liabilities therefore no longer existed after April 2025.
As at 30 September 2025, liabilities include approximately £533k classified as held for sale for the 3radical Group. These entities are in liquidation and the Company has no obligation to settle these amounts.
In assessing the ability of the Company to continue as a going concern and pay its debts as and when they fall due, the directors have taken into consideration the following matters:
On 13 October 2025, the CVA was completed with 236,782,175 new Ordinary shares issued in satisfaction of all the CVA debts, and the outstanding £45,000 of CLNs were converted into 306,665,817 new Ordinary shares, leaving the Company completely free of all its pre-CVA debts.
Management and the directors have considered each of these matters and what the enlarged Group (Electric Guitar PLC as potentially enlarged by the RTO of Dunbar) is expected to look like following the completion of the anticipated RTO, which will only be completed on the basis that the transaction includes sufficient working capital for the enlarged Group's requirements for at least 12 months after completion of the RTO.
NOTES TO THE INTERIM FINANCIAL STATEMENTS
The directors have also assessed the Company's ability to continue as a standalone entity in the event no acquisition is pursued and completed in the period to December 2026.
Cashflow projections have also been prepared on this basis which support the directors' view that the Company has sufficient facilities to meet its obligations for the period to 31 December 2026 and pay its debts as they fall due. There is, however, no guarantee the directors would be successful in raising additional financing for its future growth and working capital should this be required. This matter indicates that a material uncertainty exists that may cast significant doubt on the ability of the Company to continue as a going concern at the time of approval of the condensed financial statements.
The key matters assessed by the directors in considering the ability of the Company to continue as a going concern for the period to 31 December 2026 are summarised below.
- The directors have assessed the ability of the Company to continue as a going concern both as a standalone entity (should the anticipated RTO not complete) and in the anticipated scenario where the RTO of Dunbar concludes. The proposed terms of the Dunbar acquisition include a condition requiring Dunbar to have raised sufficient working capital for the enlarged Group for 18 months. There is however no guarantee that the proposed transaction will be completed in accordance with the proposed terms or that the Group, as enlarged by the RTO of Dunbar, will perform in accordance with any projections prepared for the period following completion.
- Management has prepared detailed cashflow forecasts for the Company on a standalone basis (should the anticipated RTO not proceed to completion) and the management of Dunbar is preparing similar forecasts for the enlarged Group for the 18-month period following completion of the proposed RTO of Dunbar. Before entering into binding contracts to acquire Dunbar, the directors will review and approve Dunbar's forecasts, following thorough testing of them by the Company's RTO reporting accountants.
- As part of its assessment of the forecasts, certain sensitivity analyses will be run on the forecast model for the enlarged Group. In the event the enlarged Group's actual sales for the period ending 12 months after completion of the proposed RTO would be lower than forecast and certain controllable costs were to be deferred, the tests will be required to show that the Group should still have the ability to operate and pay its debts as and when they fall due for the same period as above, but this cannot be guaranteed.
- In the event that the proposed RTO does not proceed, and no other acquisitions are pursued in the year to 31 December 2026, the Company would continue to be a cash shell. As noted above, the standalone forecasts prepared by the Company show that the Company has sufficient facilities to meet its obligations for the period to 31 December 2026 and pay its debts as they fall due.
NOTES TO THE INTERIM FINANCIAL STATEMENTS
- There is, however, no guarantee the directors would be successful in raising additional financing for its future growth and working capital should this be required.
The financial statements do not include adjustments should the going concern basis be inappropriate. Nonetheless, in view of the successful track record of raising financing in the last year from both equity and debt sources and other available funding options, the directors are confident they would be successful in raising any necessary financing within the next 12 months from the date of approval of the financial statements.
For these reasons, the directors continue to adopt the going concern basis in preparing the financial statements.
The financial statements of the Group consolidate the results of the Company and its subsidiary entities. A subsidiary is an entity controlled by the Group. The Group controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its influence over the entity.
The financial statements of subsidiaries are included in the condensed consolidated financial statements from the date on which control commences until the date on which control ceases.
The consolidated financial statements present the results of the Company and its subsidiaries (the Group) as if they formed a single entity. Intercompany transactions and balances, including unrealised gains/losses between group companies are therefore eliminated in full.
Where the Group ceases to control a subsidiary, the subsidiary is deconsolidated from the date which control ceases. The net assets of the subsidiary are included in a disposal calculation along with any consideration received from the disposal, with any gain or loss recognised in the Statement of Profit and Loss.
Cash and cash equivalents comprise cash at bank.
NOTES TO THE INTERIM FINANCIAL STATEMENTS
Share capital represents the nominal value of shares that have been issued. Share premium includes any premiums received on issue of share capital. Any transactions costs associated with the issuing of shares are deducted from share premium.
Provisions are made where an event has taken place that gives the group a legal or constructive obligation that requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to the income statement in the period that the group becomes aware of the obligation and are measured at the best estimate at the reporting date of the expenditure required to settle the obligation, after taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet.
Trade and other payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accruals and accounts payable are classified as current liabilities if payment is due within one year or less. Trade payables are initially recognised at fair value and subsequently measured at amortised cost using the effective interest method.
All financial liabilities are recognised in the condensed consolidated statement of financial position when the Company or its subsidiaries becomes party to the contractual provision of a financial instrument.
Financial liabilities measured at amortised cost
Financial liabilities held at amortised cost comprise trade payables and other payables and borrowings.
These financial liabilities are initially measured at fair value net of any transaction costs directly attributable to the issue of the instrument. Such interest-bearing liabilities are subsequently measured at amortised cost using the effective interest rate method, which ensures that any interest expense over the period to repayment is at a market rate on the balance of the liability carried in the condensed consolidated statement of financial position.
NOTES TO THE INTERIM FINANCIAL STATEMENTS
for the six months ended 30 September 2025 (continued)
2. Accounting policies (continued)
Subsequent measurement
The amortised cost of a financial liability is the amount at which the financial liability is measured on initial recognition, minus the principal repayments, plus or minus the cumulative amortisation using effective interest method of any difference between the initial amount recognised and the maturity amount. Such amortisation amounts are recognised in the condensed consolidated statement of comprehensive income. Due to the short-term nature of trade and other payables, they are stated at their nominal value, which approximates their fair value.
The costs of short-term employee benefits are recognised as a liability and an expense. The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received.
2.11 Business combinations
The condensed consolidated half-year financial statements incorporate the results of Electric Guitar plc and its subsidiaries as at 30 September 2025 and for the six months period then ended using the acquisition method of accounting.
Business combinations falling within the scope of IFRS 3 Business Combinations are accounted for using the acquisition method as at the acquisition date, which is the date on which control is transferred to the group.
The Group measures goodwill at the acquisition date as the fair value of the consideration transferred less the fair value of identifiable assets acquired and liabilities assumed.
Costs relating to the acquisition, other than those associated with the issue of equity instruments, are expensed as incurred.
The preparation of the condensed consolidated financial statements in accordance with UK adopted IFRS requires the use of certain critical accounting estimates. It also requires management to exercise their judgment in applying the Company's accounting policies.
Estimates and judgements are continually evaluated and are based on historical experience and other factors, including future conditions that are assessed to be reasonable under the circumstances.
NOTES TO THE INTERIM FINANCIAL STATEMENTS
3. Critical accounting judgements and estimates (continued)
Critical accounting judgements applied by the directors in preparing these half-year financial statements are disclosed in the basis of preparation (Note 2.1), basis other than going concern (Note 2.3) accounting policies and the derecognition of liabilities described in Note 4 .
| 6 months ended 30 Sept 2025 |
| 6 months ended 30 Sept 2024 |
| £'000 |
| £'000 |
Derecognition of liabilities | 1,351 | - | |
| 1,351 |
| - |
The CVA Supervisor completed the administration of the CVA, and the Company issued the fixed pool of 236,782,175 new Ordinary shares to its former creditors, representing 8.6 per cent. of the enlarged equity, as approved by its creditors and members in full satisfaction of its pre-CVA liabilities. The outstanding balance of the emergency convertible loans was at the same time automatically converted into 306,665,817 new Ordinary shares, fully eliminating the rest of the Company's pre-CVA debts.
| 6 months ended 30 Sept 2025 |
| 6 months ended 30 Sept 2024 |
| £'000 |
| £'000 |
Wages and salaries | 48 | 587 | |
Social security costs | - | 64 | |
Other pension costs | - | 6 | |
| 48 |
| 657 |
During the six months ended 30 September 2025, the Company incurred one-off expenses in respect of the proposal to acquire U.S. energy company Dunbar Energy Inc. in an all-share RTO, subject (inter alia) to due diligence and approval by the Company's shareholders.
NOTES TO THE INTERIM FINANCIAL STATEMENTS
In the comparative six month period to 30 September 2024, the Company incurred costs in connection with the acquisition of subsidiaries and admission to AIM.
|
| 6 months ended 30 Sept 2025 |
| 6 months ended 30 Sept 2024 |
|
| £'000 |
| £'000 |
Professional fees - purchase of subsidiaries | - | 520 | ||
Listing fees | - | 15 | ||
Other professional fees | 259 | 50 | ||
|
| 259 |
| 585 |
Results of discontinued activities |
| 6 months ended 30 Sept 2025 |
| 6 months ended 30 Sept 2024 |
| £'000 |
| £'000 | |
Revenue | - | 57 | ||
Cost of sales | - | (34) | ||
Gross profit | - |
| 23 | |
|
|
|
| |
Impairment of goodwill | - | (2,269) | ||
Administrative expenses | - | (1,433) | ||
Operating loss |
| - |
| (3,679) |
|
|
|
|
|
Finance costs | - | (2) | ||
Loss before income tax | - |
| - | |
Income tax | - | - | ||
Net loss for the year from discontinued operations |
| -
|
| (3,681)
|
Cash flows used in discontinued operations |
|
|
| ||
Net cash used in operating activities | - | (772) | |||
Net cash used in investing activities | - | - | |||
Net cash from financing activities | - | 738 | |||
Net cash used in discontinued operations |
| (34) | |||
|
|
|
| ||
NOTES TO THE INTERIM FINANCIAL STATEMENTS
Basic earnings per share is calculated by dividing the profit/ (loss) attributable in the period to equity holders of the Company by the weighted average number of Ordinary shares in issue during the period, excluding any Ordinary shares purchased by the Company and held as treasury shares.
| 6 months ended 30 Sept 2025 |
| 6 months ended 30 Sept 2024 |
|
|
|
|
Profit / (loss) for the period attributable to equity holders of the Company (£'000): | |||
- Continuing activities | 900 | - | |
- Discontinued activities | - | (4,268) | |
Weighted average number of Ordinary shares (basic) | 1,771,471,843 | 200,322,398 | |
| |||
Weighted average number of Ordinary shares (diluted) | 2,105,960,653 | 200,322,398 | |
Basic earnings / (loss) per share (pence): |
|
| |
- Continuing activities | 0.05 |
| - |
- Discontinued activities | - |
| (2.13) |
| 0.05 |
| (2.13) |
Diluted earnings / (loss) per share (pence): |
|
| |
- Continuing activities | 0.04 |
| - |
- Discontinued activities | - |
| (2.13) |
| 0.04 |
| (2.13) |
For the comparative period, share warrants issued by the Company have an anti-dilutive effect on loss per share. Hence, under IFRS diluted loss per share is shown as being the same as basic loss per share.
NOTES TO THE INTERIM FINANCIAL STATEMENTS
|
30 Sept 2025 |
|
31 March 2025 |
| £'000 |
| £'000 |
Issued and fully paid | |||
2.21m Ordinary shares of 0.01p each and 257.1m Deferred shares of 0.49p each (31/3/25 - 257.1m Ordinary shares of 0.01p each and 257.1m Deferred shares of 0.49p each ) |
1,481 |
1,286 |
Movements in issued share capital during the six months ended 30 September 2025 were as follows:
| No. of Ordinary shares of 0.01p each | Nominal Value £'000 | Share premium £'000 |
| ||||
At beginning of period |
| 257,145,740 | 1,286 | 3,704 |
| |||
|
|
|
|
| ||||
Shares issued - Subscription shares |
|
875,000,000 |
87 |
213 | ||||
- CLN shares |
| 68,147,959 | 7 | 3 |
| |||
- Placing of shares |
| 968,750,000 | 97 | 678 |
| |||
- Shares issued in settlement of fees |
| 37,500,000 | 4 | 26 |
| |||
- Costs of share issues |
| - | - | (39) |
| |||
At end of period |
| 2,206,543,699 | 1,481 | 4,585 |
| |||
On 2 April 2025, the Company issued Ordinary shares pursuant to the CVA Proposals having been approved:
- Completion of a fundraise by way of Subscription for 875,000,000 new Ordinary shares in the Company at 0.034p per Ordinary share for a total of £300,000;
- a total of 68,147,959 new Ordinary shares were issued pursuant to the automatic conversion of £10,000 of CLNs in accordance with, inter alia, completion of the Subscription;
On 18 June 2025, the Company raised £775,000 (before expenses) by way of a placing ('the Placing') of a total of 968,750,000 new Ordinary shares of 0.01 pence each in the Company at a price of 0.08 pence per new Ordinary share.
The net proceeds of the Placing are being used to fund the Company's anticipated costs of an acquisition and for general working capital.
NOTES TO THE INTERIM FINANCIAL STATEMENTS
On the same date, the Company announced that Novum Securities Limited (now AlbR Capital Limited) had been appointed as a Joint Broker to the Company with immediate effect. To keep the Company's running costs low, it issued 37,500,000 new Ordinary shares to Novum at the issue price of 0.08 pence per share in full satisfaction of its £30,000 annual broking retainer fee.
Issue of warrants
On 6 May 2025, the Company agreed to issue, in aggregate, 100,000,000 warrants to subscribe for new Ordinary shares to Richard Horwood and Sarfraz Munshi on the following terms, to align their interests with those of all the shareholders, and to compensate them for their unremunerated work:
Richard Horwood | Sarfraz Munshi | ||
Warrant Terms | Number | Number | Total |
Exercise price £0.001 for a term of 12 months from 13 October 2025, the date of admission of the CVA Creditor Shares | 25,000,000 | 25,000,000 | 50,000,000 |
Exercise price £0.0015 for a term of 18 months from 13 October 2025, the date of admission of the CVA Creditor Shares | 25,000,000 | 25,000,000 | 50,000,000 |
The warrants cannot be exercised if it would cause either of the directors (and those deemed to be acting in concert with him) to be interested in more than 29.99% of the issued share capital and total voting rights of the Company at any time. The issue of the warrants to Mr Horwood and Mr Munshi are deemed related party transactions pursuant to Rule 13 of the AIM Rules for Companies.
A summary of the warrants and options granted in the period ended 30 September 2025 is as follows:
2024 Warrants | CLN Warrants | 2025 Warrants | Employee Plan Options | Consultant Plan Options | |
Outstanding at 31 March 2025 | 6,920,990 | 187,406,889 |
- | 24,442,015 | 9,628,268 |
Issued in the period | - | - | 100,000,000 | - | - |
Outstanding at 30 September 2025 | 6,920,990 | 187,406,889 |
100,000,000 | 24,442,015 | 9,628,268 |
The total expense recognised in the Statement of Comprehensive Income during the period ended 30 September 2025 in respect of the awards over Ordinary shares was £20,000 (2024: £49,000).
NOTES TO THE INTERIM FINANCIAL STATEMENTS
for the six months ended 30 September 2025 (continued)
Share premium account
The share premium account includes any premiums received on issue of share capital.
Any transaction costs associated with the issuing of shares are deducted from share premium.
Share-based payment reserve
The share based payment reserve represents the cumulative fair value of the charge/(credit) in respect of share warrants granted and recognised as an expense in the Income Statement.
Foreign currency translation reserve
The translation reserve comprises translation differences arising from the translation of financial statements of the Group's foreign entities into Sterling (£).
Accumulated losses
This reserve records accumulated losses brought forward and carried forward.
30 Sept 2025 | 31 March 2025 | ||
| £'000 |
| £'000
|
| |||
Current liability: | |||
Convertible loan notes | 45 | 55 | |
Convertible loan notes
In order to provide the necessary cashflow to facilitate preparation for a CVA proposal to be put to creditors, Sanderson Capital Partners Limited and Grahame Cook (a director), being connected creditors, advanced to the Company £45,000 and £10,000 respectively as Convertible Unsecured Loans, which, conditional upon approval by creditors and shareholders of the proposal, were to be converted to 374,813,777 new Ordinary shares.
Grahame Cook's £10,000 loan was converted on 2 April 2025, as described above, and Sanderson's £45,000 convertible loan converted upon the issue of the new Ordinary shares in the Company being issued under the CVA in October 2025.
|
30 Sept 2025 |
|
31 March 2025 |
|
|
|
|
Trade creditors | 62 | 616 | |
Social security and other taxes | - | 97 | |
Pension payable to directors' personal SIPPs | - | 57 | |
Accrued expenses and deferred income | 23 | 572 | |
Other creditors | - | 62 | |
| 85 |
| 1,404 |
Trade payables and accruals primarily comprise amounts payable for services received from third parties. The Group has financial risk management policies in place to monitor that all payables are paid within the pre-agreed credit terms. The directors consider that the fair value approximates the carrying value.
3radical Limited and its subsidiaries and Mymyne Limited are presented as a disposal group held for sale following the appointment of the liquidators for 3radical and the striking off notice for Mymyne.
The expected settlement of the disposal group is not known at the date of this report.
|
30 Sept 2025 |
|
31 March 2025 |
Assets classified as held for sale: |
|
|
|
Plant and equipment | 1 | 1 | |
Cash at bank | 18 | 18 | |
Trade and other receivables | 13 | 13 | |
Total | 32 |
| 32 |
|
30 Sept 2025 |
|
31 March 2025 |
Liabilities classified as held for sale: |
|
|
|
Trade and other payables | 543 | 543 | |
Borrowings | 27 | 27 | |
Total | 570 |
| 570 |
During the period, the Company entered into the following transactions with related parties, all of which were conducted on an arm's length basis:
· See note 10 for details of transactions entered into with Sanderson Capital and Grahame Cook with regard to the issue of convertible loan notes during the reporting period.
· In May 2025, the Company agreed to issue, in aggregate, 100,000,000 warrants to subscribe for new Ordinary shares as disclosed in Note 9 above.
· In June 2025, as part of a placing to raise £775k, Sanderson Capital and Mayford 1TN Limited each subscribed for 187,500,000 new Ordinary shares. As substantial shareholders with 13.88 per cent. and 29.16 per cent. respectively of the Company's issued share capital, their participation in the placing was a related party transaction pursuant to Rule 13 of the AIM Rules for Companies.
· In August and October 2025, the Company paid John Regan, a former director who stepped down on 1 April 2025 and was therefore still a related party under AIM Rules for Companies, a total fee of £10,000 to assist the Company in administering the processes leading up to the proposed RTO and other matters. An additional fee of £2,000 that would be self-financing and payable only if and when received by the Company, has not yet been paid.
Completion of CVA
On 13 October 2025, the CVA Supervisor completed the administration of the CVA, and the Company issued the fixed pool of 236,782,175 new Ordinary shares to its former creditors at 0.014674 per share, amounting to £34,745 and representing 8.6 per cent. of the enlarged equity, as approved by its creditors and members in full satisfaction of its pre-CVA liabilities.
The outstanding balance of the emergency convertible loans of £45,000 was at the same time automatically converted into 306,665,817 new Ordinary shares (at 0.014674 per share), fully eliminating the rest of the Company's pre-CVA debts.
The Company considers that there is no ultimate controlling party.
Email this article to a friend
or share it with one of these popular networks:
You are here: news